Hydroxy-safflower yellow A composites: An effective strategy to enhance anti-myocardial ischemia by improving intestinal permeability.

Dandan Bao, Xiaowei Xie, Mengying Cheng, Ke Zhang, Tianxiang Yue, Aidi Liu, Weixiang Fang, Yinghui Wei, Hangsheng Zheng, Ji-Gang Piao, Donghang Xu, Yuxian Li

International journal of pharmaceutics 2022 Jul 25

filter terms:

Hydroxy-safflower yellow A (HSYA) is the chief component of safflower against myocardial ischemia (MI), and belongs to biopharmaceutics classification system (BCS) III drugs. Its structure contains multiple hydroxyl groups, contributing to its high polarity and poor oral bioavailability. The main objective of this study was to probe the potential of oral penetration enhancer n-[8-(2-hydroxybenzoyl) amino] sodium octanoate (SNAC) and cationic copolymer Eudragit®EPO (EPO) to promote absorption of HSYA. HSYA composites (SNAC-HSYA-EPO) were formed by hydrogen bonding and van der Waals force. SNAC-HSYA-EPO has biocompatibility, and can improve the membrane fluidity, uptake, transport, and penetration of Caco-2 cells. The mechanism of promoting of SNAC-HSYA-EPO may be related to energy and P-glycoprotein (P-gp) when compared with the inhibitor NaN3 and verapamil group. In the pharmacokinetic (PK) results, SNAC-HSYA-EPO significantly improved oral bioavailability. Pharmacodynamics (PD) results determined that SNAC-HSYA-EPO could improve the symptoms of MI. The mechanism of the SNAC-HSYA-EPO anti-MI is related to alleviating inflammation and anti-apoptosis to protect the heart. In summary, SNAC-HSYA-EPO prepared in this study possessed a complete appearance, high recombination rate and excellent oral permeability promoting ability. SNAC-HSYA-EPO has the potential to improve oral bioavailability and further enhance the anti-MI effect of HSYA. Copyright © 2022 Elsevier B.V. All rights reserved.

Citation

Dandan Bao, Xiaowei Xie, Mengying Cheng, Ke Zhang, Tianxiang Yue, Aidi Liu, Weixiang Fang, Yinghui Wei, Hangsheng Zheng, Ji-Gang Piao, Donghang Xu, Yuxian Li. Hydroxy-safflower yellow A composites: An effective strategy to enhance anti-myocardial ischemia by improving intestinal permeability. International journal of pharmaceutics. 2022 Jul 25;623:121918